Communication - IIS Aragón

November 15, 2024
Posted by Communication - IIS Aragón el November 15, 2024
Categories

The IIS Aragón presents a video that highlights scientific advances in the care of premature babies

On the occasion of Premature Babies Day, which is celebrated this coming Sunday, the IIS Aragón has presented the video “Premature babies by the hand of science” to highlight the scientific advances in the care and treatment of these babies.
Do you like it?
Read more
November 15, 2024
Posted by Communication - IIS Aragón el November 15, 2024
Categories

Jorge Rubio Gracia: “We face a high level of competition to obtain human and economic resources”

In this interview, the IIS Aragón researcher talks about his work leading the 'Heart Failure Research Group' (GIIS043) and what his most notable project is.
Do you like it?
Read more
November 14, 2024
Posted by Communication - IIS Aragón el November 14, 2024
Categories

New therapeutic approach for severe COVID-19: faster recovery and reduced mortality

An international study, with the participation of the University of Zaragoza and the Aragón Health Research Institute (IIS Aragón), has tested a new therapeutic strategy to treat severe COVID. It is a clinical trial whose results are published in eClinicalMedicine and which could also be applied to other respiratory viruses.
Do you like it?
Read more
November 13, 2024
Posted by Communication - IIS Aragón el November 13, 2024
Categories

ASEICA organizes a “Week of Science in Cancer” with an international congress that will bring together 400 experts

The activities of the “Science Week” in Zaragoza will run from 12 to 16 November 2024. In addition to various informative days and meetings between patients and researchers, several grants will be awarded for cancer research worth a total of 345.000 euros.
Do you like it?
Read more
November 11, 2024
Posted by Communication - IIS Aragón el November 11, 2024
Categories

A new drug promises to curb multiple sclerosis, Parkinson's and Alzheimer's

Researchers at University College London and Loyola University have developed a modified compound of cyclosporin A that blocks cyclophilin D in the brain, offering a new avenue for treating neurodegenerative diseases. Early animal studies show promising results.
Do you like it?
Read more
November 8, 2024
Posted by Communication - IIS Aragón el November 8, 2024
Categories

The IIS Aragón participates in the REGIC Annual Conference

This year, the conference, organised by the Network of Clinical Research Management Entities (REGIC), is being held in Barcelona and the IIS Aragón is once again taking part in this important event.
Do you like it?
Read more
November 7, 2024
Posted by Communication - IIS Aragón el November 7, 2024
Categories

A high-resolution macrostudy opens the door to tightening the noose in the fight against cancer

Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, reflects on cancer following the publication of the series of articles by the Nature group, which represent an unprecedented analysis of this disease, turning everything known upside down.
Do you like it?
Read more
November 5, 2024
Posted by Communication - IIS Aragón el November 5, 2024
Categories

DIVE Medical helps diagnose visual and neurocognitive problems in childhood

The company, which has specialists in ophthalmology and optometry from the IIS Aragón and the IACS, uses technology based on artificial intelligence to objectively explore vision in any patient through gaze tracking.
Do you like it?
Read more
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354